ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2010 | 19.71 Million USD | 15.4% |
| 2009 | 17.08 Million USD | 72112.06% |
| 2008 | 23.65 Thousand USD | -71.54% |
| 2007 | 83.13 Thousand USD | 71.86% |
| 2006 | 48.37 Thousand USD | 21.2% |
| 2005 | 39.91 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2011 Q1 | 22.9 Million USD | 16.19% |
| 2011 Q3 | 26.01 Million USD | 18.92% |
| 2011 Q2 | 21.87 Million USD | -4.48% |
| 2010 Q3 | 20.17 Million USD | 7.99% |
| 2010 Q2 | 18.68 Million USD | -7.05% |
| 2010 FY | 19.71 Million USD | 15.4% |
| 2010 Q1 | 20.09 Million USD | 17.64% |
| 2010 Q4 | 19.71 Million USD | -2.28% |
| 2009 Q2 | - USD | -100.0% |
| 2009 Q4 | 17.08 Million USD | 22.63% |
| 2009 FY | 17.08 Million USD | 72112.06% |
| 2009 Q1 | 27.73 Thousand USD | 17.24% |
| 2009 Q3 | 13.93 Million USD | 0.0% |
| 2008 FY | 23.65 Thousand USD | -71.54% |
| 2008 Q3 | 25.11 Thousand USD | -7.19% |
| 2008 Q4 | 23.65 Thousand USD | -5.78% |
| 2008 Q2 | 27.05 Thousand USD | -6.56% |
| 2008 Q1 | 28.95 Thousand USD | -65.17% |
| 2007 FY | 83.13 Thousand USD | 71.86% |
| 2007 Q2 | 34.4 Thousand USD | -4.81% |
| 2007 Q3 | 45.38 Thousand USD | 31.91% |
| 2007 Q4 | 83.13 Thousand USD | 83.19% |
| 2007 Q1 | 36.14 Thousand USD | -25.29% |
| 2006 Q4 | 48.37 Thousand USD | 0.0% |
| 2006 FY | 48.37 Thousand USD | 21.2% |
| 2005 FY | 39.91 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 52.151% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -378.293% |
| SQZ Biotechnologies Company | 27.47 Million USD | 28.233% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 54.545% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 33.769% |
| Mesoblast Limited | 118.7 Million USD | 83.391% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -1979.049% |
| Genus plc | 233.1 Million USD | 91.542% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -572.779% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -1367.346% |
| Marizyme, Inc. | 18.71 Million USD | -5.329% |
| ContraFect Corporation | 2.88 Million USD | -584.312% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -2528.669% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -14451.227% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -1263.117% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -747.61% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -248.423% |
| MultiCell Technologies, Inc. | 202.58 USD | -9731868.111% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 65.706% |
| EV Biologics, Inc. | 1.49 Million USD | -1218.95% |
| Q BioMed Inc. | 4.1 Million USD | -379.686% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 40.44% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -3028.986% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -1504.986% |
| Biomind Labs Inc. | 735.54 Thousand USD | -2580.339% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 88.507% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -51.689% |
| Skye Bioscience, Inc. | 4.61 Million USD | -327.17% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -2120.0% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -13831.105% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -235.798% |
| IMV Inc. | 28.88 Million USD | 31.744% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -76555.473% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -772.971% |
| GB Sciences, Inc. | 1.75 Million USD | -1020.613% |
| Alpha Cognition Inc. | 1.22 Million USD | -1515.493% |
| HST Global, Inc. | 98.31 Thousand USD | -19952.097% |
| CSL Limited | 12.18 Billion USD | 99.838% |
| Halberd Corporation | 150 Thousand USD | -13043.347% |
| Enzolytics Inc. | 996.33 Thousand USD | -1878.748% |
| Resverlogix Corp. | 6.49 Million USD | -203.729% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -4028.8% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -7613.473% |
| argenx SE | 20 Million USD | 1.425% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 56.727% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -627.84% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -192711.941% |
| Genscript Biotech Corporation | 417.73 Million USD | 95.281% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -9727.243% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -722.239% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -8498.253% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 70.854% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -551.48% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -5380.81% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 3.015% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -13162.355% |
| BioStem Technologies, Inc. | 4.71 Million USD | -318.452% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -7780.272% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -7826.593% |
| Agentix Corp. | 50 Thousand USD | -39330.042% |
| LadRx Corporation | 33.6 Thousand USD | -58565.182% |
| Cell Source, Inc. | 9.25 Million USD | -113.039% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -2507.104% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -2507.104% |
| NovAccess Global Inc. | 2.19 Million USD | -796.186% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -178.744% |
| Itoco Inc. | 228.37 Thousand USD | -8532.665% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -9244.719% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -295.646% |
| Kadimastem Ltd | 891.22 Thousand USD | -2112.124% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -4806.077% |
| CytoDyn Inc. | 30.07 Million USD | 34.449% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -3970.963% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -5503.294% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -152.112% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -15993.895% |
| Rebus Holdings, Inc. | 310 Thousand USD | -6259.684% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -316.343% |
| International Stem Cell Corporation | 4.17 Million USD | -371.877% |
| Bioxytran, Inc. | 1.92 Million USD | -924.157% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -31488.004% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -803.986% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -137.073% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -129.645% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -1167.457% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -7256.351% |
| Neutra Corp. | 54.15 Thousand USD | -36304.131% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -977.324% |
| PureTech Health plc | 25.51 Million USD | 22.723% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -1510.407% |
| IXICO plc | 472.02 Thousand USD | -4076.708% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -27.185% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 68.336% |
| CSL Limited | 12.18 Billion USD | 99.838% |
| Cellectis S.A. | 92.77 Million USD | 78.75% |